(Q42666627)
Statements
1 reference
The Rilutek (riluzole) Global Early Access Programme: an open-label safety evaluation in the treatment of amyotrophic lateral sclerosis (English)
1 reference
Debove C
1 reference
Zeisser P
1 reference
Salzman PM
1 reference
Powe LK
1 reference
Truffinet P
1 reference
1 September 2001
1 reference
2
1 reference
3
1 reference
153-158
1 reference
Identifiers
1 reference
1 reference